x82

Vorolanib (X-82) is an orally active VEGFR/PDGFR dual inhibitor.

RX821002 is a potent and selective antagonist of α2-adrenoceptor with low affinity for imidazoline sites. RX821002 displays selectivity for the α2D over the α2A subtypes (pKd values are 9.7 and 8.2 respectively).

Tyrphostin 23 (AG18) inhibits EGFR with IC50 of 35 μM.

Efaroxan hydrochloride is the salt form of Efaroxan, a selective, orally available α2-adrenoceptor antagonist that raises resting plasma insulin levels and significantly potentiates adrenaline-induced increases in insulin levels.

L-Albizziin (2-Methoxyidazoxan monohydrochloride) is a highly potent selective antagonist of the alpha 2r adrenergic receptor, with little or no antagonistic effect on imidazoline. It has a significantly higher affinity for the alpha 2D adrenergic receptor (pKd9.7) in guinea pigs than for the alpha 2A adrenergic receptor (pKd8.2) in rabbits.